STAGE I BLADDER CANCER AJCC V8

This early-stage trial is testing a new targeted treatment for bladder cancer that has returned or hasn't responded to standard therapy. Researchers are using microscopic particles designed to deliver cancer-killing medication directly to tumor cells in the bladder. The study wil…

This large, late-stage trial is testing if adding a chemotherapy drug called gemcitabine to the standard BCG treatment is more effective at controlling recurrent, high-grade bladder cancer that hasn't invaded the muscle wall. The study will compare the combination treatment again…

This study is testing whether a common bladder cancer treatment can be safely and effectively given at home instead of requiring frequent clinic visits. It will involve about 40 patients with early-stage bladder cancer who are already receiving standard liquid chemotherapy placed…

This early-stage study is testing whether a new vaccine (IO102-IO103) combined with an existing immunotherapy drug (pembrolizumab) is safe and effective for patients with high-risk bladder cancer that hasn't responded to standard BCG treatment. The vaccine is designed to teach th…

This study is for people with a specific type of high-grade bladder cancer that has not spread into the muscle wall. It compares two different treatment combinations, both given with radiation therapy. One group gets a standard chemotherapy drug, while the other gets an immunothe…

This study is testing whether a personalized home exercise program delivered through a smartphone app can help people with early-stage bladder cancer become more physically active. Researchers will compare the app, which provides exercise videos and step goals, to a group that on…

This study aims to understand how different treatments for early-stage bladder cancer affect patients' quality of life over time. Researchers will follow 704 survivors for three years, asking them to complete surveys about their physical, emotional, and social well-being. The goa…